118 related articles for article (PubMed ID: 34767964)
1. HOXD9 transcriptionally induced UXT facilitate breast cancer progression via epigenetic modification of RND3.
Hu XC; Chu J; Zhou Y; Li CC; Zhou GJ; Jiang GQ
Cell Signal; 2022 Feb; 90():110188. PubMed ID: 34767964
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitous expressed transcript promotes tumorigenesis by acting as a positive modulator of the polycomb repressive complex 2 in clear cell renal cell carcinoma.
Zeng J; Xiang W; Zhang Y; Huang C; Chen K; Chen Z
BMC Cancer; 2019 Sep; 19(1):874. PubMed ID: 31481081
[TBL] [Abstract][Full Text] [Related]
3. Long Non-Coding RNA HOXA-AS2 Enhances The Malignant Biological Behaviors In Glioma By Epigenetically Regulating RND3 Expression.
Wu L; Zhu X; Song Z; Chen D; Guo M; Liang J; Ding D; Wang W; Yan D
Onco Targets Ther; 2019; 12():9407-9419. PubMed ID: 31819475
[TBL] [Abstract][Full Text] [Related]
4. UXT Is a LOX-PP Interacting Protein That Modulates Estrogen Receptor Alpha Activity in Breast Cancer Cells.
Sánchez-Morgan N; Kirsch KH; Trackman PC; Sonenshein GE
J Cell Biochem; 2017 Aug; 118(8):2347-2356. PubMed ID: 28106301
[TBL] [Abstract][Full Text] [Related]
5. UXT, a novel DNMT3b-binding protein, promotes breast cancer progression via negatively modulating lncRNA MEG3/p53 axis.
Huang ZF; Tang YL; Shen ZL; Yang KY; Gao K
Mol Ther Oncolytics; 2022 Mar; 24():497-506. PubMed ID: 35229028
[TBL] [Abstract][Full Text] [Related]
6. Highly expressed miR-182-5p can promote preeclampsia progression by degrading RND3 and inhibiting HTR-8/SVneo cell invasion.
Fang YN; Huang ZL; Li H; Tan WB; Zhang QG; Wang L; Wu JL
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6583-6590. PubMed ID: 30402829
[TBL] [Abstract][Full Text] [Related]
7. HOXD9 promote epithelial-mesenchymal transition and metastasis in colorectal carcinoma.
Liu M; Xiao Y; Tang W; Li J; Hong L; Dai W; Zhang W; Peng Y; Wu X; Wang J; Chen Y; Bai Y; Lin J; Yang Q; Wang Y; Lin Z; Liu S; Xiong J; Wang J; Xiang L
Cancer Med; 2020 Jun; 9(11):3932-3943. PubMed ID: 32281284
[TBL] [Abstract][Full Text] [Related]
8. The long non-coding RNA DANCR regulates the inflammatory phenotype of breast cancer cells and promotes breast cancer progression via EZH2-dependent suppression of SOCS3 transcription.
Zhang KJ; Tan XL; Guo L
Mol Oncol; 2020 Feb; 14(2):309-328. PubMed ID: 31860165
[TBL] [Abstract][Full Text] [Related]
9. Chaperone-mediated autophagy regulates proliferation by targeting RND3 in gastric cancer.
Zhou J; Yang J; Fan X; Hu S; Zhou F; Dong J; Zhang S; Shang Y; Jiang X; Guo H; Chen N; Xiao X; Sheng J; Wu K; Nie Y; Fan D
Autophagy; 2016; 12(3):515-28. PubMed ID: 26761524
[TBL] [Abstract][Full Text] [Related]
10. EZH2-mediated Epigenetic Silencing of miR-29/miR-30 targets LOXL4 and contributes to Tumorigenesis, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.
Yin H; Wang Y; Wu Y; Zhang X; Zhang X; Liu J; Wang T; Fan J; Sun J; Yang A; Zhang R
Theranostics; 2020; 10(19):8494-8512. PubMed ID: 32754259
[TBL] [Abstract][Full Text] [Related]
11. HOXD9 promotes the growth, invasion and metastasis of gastric cancer cells by transcriptional activation of RUFY3.
Zhu H; Dai W; Li J; Xiang L; Wu X; Tang W; Chen Y; Yang Q; Liu M; Xiao Y; Zhang W; Lin J; Wang J; Liu G; Sun Y; Jiang P; Li G; Li A; Liu S; Chen Y; Wang J
J Exp Clin Cancer Res; 2019 Sep; 38(1):412. PubMed ID: 31547840
[TBL] [Abstract][Full Text] [Related]
12. HOXD9‑induced SCNN1A upregulation promotes pancreatic cancer cell proliferation, migration and predicts prognosis by regulating epithelial‑mesenchymal transformation.
Chang J; Hu X; Nan J; Zhang X; Jin X
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34558641
[TBL] [Abstract][Full Text] [Related]
13. The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degradation of UXT isoform 2 (UXT-V2) to inhibit the NF-κB signaling pathway.
Spagnol V; Oliveira CAB; Randle SJ; Passos PMS; Correia CRSTB; Simaroli NB; Oliveira JS; Mevissen TET; Medeiros AC; Gomes MD; Komander D; Laman H; Teixeira FR
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129754. PubMed ID: 33010352
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.
Hirao N; Iwata T; Tanaka K; Nishio H; Nakamura M; Morisada T; Morii K; Maruyama N; Katoh Y; Yaguchi T; Ohta S; Kukimoto I; Aoki D; Kawakami Y
Gynecol Oncol; 2019 Nov; 155(2):340-348. PubMed ID: 31477279
[TBL] [Abstract][Full Text] [Related]
15. Suppression of RND3 activity by AES downregulation promotes cancer cell proliferation and invasion.
Xia H; Li M; Chen L; Leng W; Yuan D; Pang X; Chen L; Li R; Tang Q; Bi F
Int J Mol Med; 2013 May; 31(5):1081-6. PubMed ID: 23546594
[TBL] [Abstract][Full Text] [Related]
16. Rnd3 regulation of the actin cytoskeleton promotes melanoma migration and invasive outgrowth in three dimensions.
Klein RM; Aplin AE
Cancer Res; 2009 Mar; 69(6):2224-33. PubMed ID: 19244113
[TBL] [Abstract][Full Text] [Related]
17. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
[TBL] [Abstract][Full Text] [Related]
18. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI.
Li LL; Xue AM; Li BX; Shen YW; Li YH; Luo CL; Zhang MC; Jiang JQ; Xu ZD; Xie JH; Zhao ZQ
Breast Cancer Res; 2014 May; 16(3):R56. PubMed ID: 24886710
[TBL] [Abstract][Full Text] [Related]
19. RND3 promotes Snail 1 protein degradation and inhibits glioblastoma cell migration and invasion.
Liu B; Dong H; Lin X; Yang X; Yue X; Yang J; Li Y; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Mao S; Chen Q; Chang J
Oncotarget; 2016 Dec; 7(50):82411-82423. PubMed ID: 27705942
[TBL] [Abstract][Full Text] [Related]
20. HOXD9 aggravates the development of cervical cancer by transcriptionally activating HMCN1.
Wen D; Wang L; Tan S; Tang R; Xie W; Liu S; Tang C; He Y
Panminerva Med; 2022 Dec; 64(4):532-536. PubMed ID: 32414224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
